Guest Post by Alex Berenson

I don’t know anything about seed oils (except that they sound vaguely pornographic) or fluoride, but here are 10 ideas that would shake up our $4 trillion healthcare-industrial complex

If Robert F. Kennedy Jr. could press even half of these through, he would be a success as Secretary of Health and Human Services, whatever else happens.

(This is a non-exhaustive list; feel free to add your own suggestions.)

• Find a constitutionally viable way to limit prescription drug advertising. A full ban is impossible, but tighter restrictions can pass First Amendment muster if they’re carefully crafted.
• Declassify and release all documents the National Institutes of Health possesses related to the lab-leak theory of Sars-Cov-2, focusing on those on the relationship between Dr. Ralph Baric and Dr. Anthony Fauci.
• Update the 2006 pandemic plan, emphasizing the lessons learned from the Covid crisis and the need to keep schools open and society functioning normally.
• Push repeal of the 1986 law that gives vaccine manufacturers essentially total immunity for vaccine-caused injuries.
• Tighten the restrictions on physician-owned and -financed outpatient medical centers; American physicians are extremely well-paid and should not be in the business of profiting from the procedures they prescribe.
• Limit compensation of executives at non-profit hospitals and chains, by, for example, saying that no non-profit executive can receive more than $1 million annually in total compensation as a condition of Medicare participation. (Make it $2 million if you must.)
• Fund a full investigation into the health impacts of the Covid mRNA vaccines, including known side effects like myocarditis as well as potentially serious changes like the IgG4 class switch.
• Declassify and release all documents related to Operation Warp Speed, focusing on those discussing whether its members ever considered forcing vaccine companies to participate in a head-to-head trial.
• Encourage generic “biosimilars” for very, very expensive prescription biologics like Humira to make them as common as generic small-molecule competitors to drugs like Lipitor.
• End the revolving door between the agencies and the medical-industrial complex and Big Pharma in particular by instituting a rule that no senior regulator may take a job or board membership at a healthcare company for at least three years, and no commissioner or C-suite member for at least a decade. Call it the Gottlieb rule, in honor of Dr. Scott Gottlieb, former Food and Drug Administration commissioner, current Pfizer board member and defendant in Berenson v Biden.